vcvibes

Modi Ventures Tbf

Emerging manager

Built from this firm's Form D filings. The firm files no SEC adviser report.

HQ
TX

Modi Ventures makes early stage investments in technology platforms that have a positive impact on health. Sahir Ali is a founder and general partner, and the team includes principals, associates, and advisors. Portfolio companies span cancer therapies, AI diagnostics, AI drug discovery, and AI networking for data centers.

01 · Says / Does

TagSaysDoes
StagesNot statedNot enough dated deals
SectorsHealthtech, Biotech, Synthetic biologyNot enough dated deals
RegionsNot statedNot enough dated deals

Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.

02 · Fund history

FundYearSizeStatus
Modi Ventures TBF II, LP

Modi Ventures makes early stage investments in technology platforms that have a positive impact on health, at the intersection of technology and biology. Focus areas include AI, microfluidics, multiomics, precision medicine, synthetic biology, gene editing, and living therapies. Inferred from the firm's website

2025$85.34M (Form D)Open, writing first checks

03 · People across funds

04 · Recent deals

No dated deals found yet.

05 · Latest from the firm

No news from the firm's website yet.

06 · Sources

  1. https://www.modivc.com
  2. https://www.modivc.com/contact
  3. https://www.modivc.com/portfolio
  4. https://www.modivc.com/portfolio-companies-collection?category=Therapeutics
  5. https://www.modivc.com/about-us
  6. https://www.modivc.com/

Fund dates and sizes are from SEC Form D filings.

Last verified: Oct 28, 2026